- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Upstart Holdings, Inc. (UPST) Rating Raised by BTIG as Bank Charter Could Reduce Funding Risk | ||
| Mo | BMO Highlights Alaska Air Group, Inc. (ALK) Earnings Expansion Potential Despite Fuel Cost Uncertainty | ||
| Mo | Orla Mining Ltd. (ORLA) Reports Q4 Revenue of $378.5M, Up From $92.8M YoY | ||
| Mo | BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations | ||
| Mo | VEON Ltd. (VEON)'s Uklon Launches Travel Service for Domestic and International Bus Ticket Booking | ||
| Mo | 10 Best Penny Stocks That Could Triple Your Money | ||
| Mo | Why Bullish Analysts Still See Major Upside in Gossamer Bio (GOSS) After PROSERA Setback | ||
| Mo | Analyst Initiates Sanofi (SNY) with 'Outperform' Rating | ||
| Mo | Rio Tinto Gets A$2 Billion Government Support to Keep Boyne Smelter Running | ||
| Mo | Blackstone-Backed Consortium Acquires Indian Cricket Franchise | ||
| Mo | Trump Administration to Pay TotalEnergies $1B to Abandon Wind Farms | ||
| Mo | Eni (E) Announces Bump in Shareholder Returns | ||
| Mo | Bristol-Myers Squibb Gets FDA Approval for Hodgkin's Lymphoma Treatment | ||
| Mo | BP Upgraded to 'Overweight', Price Target Raised to $49.40 | ||
| Mo | 13 Best Stocks to Invest In on Robinhood for Beginners | ||
| So | Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI | ||
| So | Why Vertical Aerospace (EVTL) Is Expanding Its Valo Supplier Network Ahead of Certification | ||
| So | Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab | ||
| So | Why Rezolve AI (RZLV) Is Betting Big on Reward Loyalty to Scale Commerce Media and Payments | ||
| So | Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026 | ||
| So | Why BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity | ||
| So | Why Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings | ||
| So | ACM Research (ACMR) Shanghai Unit Outlines Profit Distribution Plan For Fiscal 2025 | ||
| So | Alphabet Inc. (GOOGL) And Meta Lost a Case in Los Angeles, Here's What You Should Know | ||
| So | UBS Lowers PT on Microsoft (MSFT), Maintains a Buy Rating |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.